Navigation Links
NEXUS Biosystems Completes Acquisition of REMP Sample Management Business From Tecan Group
Date:9/8/2010

POWAY, Calif., Sept. 8 /PRNewswire/ -- NEXUS Biosystems, Inc., a leading innovator and worldwide provider of automated sample management systems, today announced the completion of the acquisition of REMP AG of Switzerland, a wholly-owned subsidiary of the Tecan Group.  

NEXUS announced on July 15, 2010 that it would acquire Tecan's worldwide REMP Sample Management business.  REMP is a leading global provider of sample management systems and related sample management devices, instruments, consumables and software.  With this acquisition, NEXUS will be adding to its current operations in the United States and Germany the REMP operations in Switzerland, Germany, Japan and the United States.  REMP provides additional R&D, manufacturing, sales and customer support operations in Switzerland and direct sales and customer support in Kawasaki, Japan.

John Lillig‚ CEO of NEXUS Biosystems, commented: "Both REMP and NEXUS have been strong innovators and leaders in the growing global automated chemical and biological sample management markets.  Together, with our new REMP colleagues, we look forward to continuing to provide leading sample management solutions to our biopharmaceutical, biorepository, diagnostic, forensic, agrochemical and genomic research customers around the world.   The combined NEXUS-REMP resources will strengthen our overall capabilities with expanded first-class service and support for our worldwide customers and a growing pipeline of new product offerings for the growing global sample management community."

About NEXUS Biosystems:

NEXUS Biosystems (www.nexusbio.com) is a leading innovator and worldwide provider of enabling technologies and automated sample management systems for pharmaceutical, biotech, biorepository, agrochemical and related research institutions worldwide.  NEXUS products include the NEXUS Universal Store family of automated ambient, -20 degrees C and -80 degrees C chemical and biological sample management systems, the REMP SSS, MSS and LSS family of automated ambient and -20C chemical and biological sample management systems, devices and sample storage containers, the Aurora line of high performance microplates, the NEXUS XPeel microplate de-sealer, and the NEXUS Crystal Farm line of protein crystallization systems.  NEXUS was founded in 2005, is headquartered in Poway, CA, has subsidiaries in Oberdiessbach Switzerland, Munich Germany, and Kawasaki Japan, and distribution offices throughout the US, Europe and Asia.

www.nexusbio.com


'/>"/>
SOURCE NEXUS Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NEXUS Biosystems Acquires Tecan Groups REMP Sample Management Business
2. AACR Data Highlights InNexus Preclinical Antibody Candidate
3. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
4. Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization (IVF)
5. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
6. Mylan Completes Acquisition of Bioniche Pharma Sooner Than Expected
7. Salinas Valley Memorial Completes Successful Implant of Cardiac Monitor and Alert System
8. CMC Biologics Completes First Stage of Expansion with Addition of Single-Use Facility
9. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
10. CeNeRx BioPharma Completes $13 Million Series C Financing
11. BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):